21 research outputs found
Association of factors with (i) wanting to start ART for modest health benefit<sup>*</sup> and (ii) wanting to start ART to reduce infectiousness<sup>*</sup> among 281 ART naïve people with CD4≥350/cells/µL.
<p>* tend to agree or strongly agree combined, versus undecided/tend to disagree/strongly disagree combined.</p><p>P values by chi-squared tests, and chi-squared tests for trend.</p>#<p>usual alcohol intake of at least 5 units 4 or more times a week, or at least 10 units 2–3 times a week.</p>$<p>score of 10 or more, based on total distress score for 19 physical symptoms, each scored 0 (symptom not present or no distress) to 4 (distressed very much by symptom).</p
Independent association of factors with (ii) wanting to start ART to reduce infectiousness<sup>*</sup> among 281 ART people who were ART naïve with CD4≥350cells/µL.
<p>* tend to agree or strongly agree combined, versus undecided/tend to disagree/strongly disagree combined;</p>#<p>using logistic regression analysis; p values by likelihood ratio test.</p
Independent association of factors with (i) wanting to start ART for modest health benefit<sup>*</sup> in ART naïve people with CD4≥350/cells/µL.
<p>*tend to agree or strongly agree combined, versus undecided/tend to disagree/strongly disagree combined.</p>#<p>using logistic regression analysis; p values by likelihood ratio test.</p>$<p>score of 10 or more, based on total distress score for 19 physical symptoms, each scored 0 (symptom not present or no distress) to 4 (distressed very much by symptom).</p
Attitudes to early ART among 281 ART naïve individuals with CD4 ≥350 cells/µL.
<p>Attitudes to early ART among 281 ART naïve individuals with CD4 ≥350 cells/µL.</p
Change in CD4 count from baseline for non-AIDS patients at 12 months for the four treatment regimens.
<p>Change in CD4 count from baseline for non-AIDS patients at 12 months for the four treatment regimens.</p
Change in CD4 count from baseline for AIDS patients at 12 months for the four treatment regimens.
<p>Change in CD4 count from baseline for AIDS patients at 12 months for the four treatment regimens.</p
Demographic characteristics and baseline viral load and CD4 count for all patients on first-line regimens.
<p>Demographic characteristics and baseline viral load and CD4 count for all patients on first-line regimens.</p
CD4 T-cell count changes at 6 and 12months for non-AIDS and AIDS patients on different first-line regimens.
<p>CD4 T-cell count changes at 6 and 12months for non-AIDS and AIDS patients on different first-line regimens.</p
Use and cost of services for AIDS patients at 6 and 12 months respectively for the four treatment regimens.
<p>Use and cost of services for AIDS patients at 6 and 12 months respectively for the four treatment regimens.</p
Use and cost of hospital services for non-AIDS patients at 6 and 12 months respectively for the four treatment regimens.
<p>Use and cost of hospital services for non-AIDS patients at 6 and 12 months respectively for the four treatment regimens.</p